$177 Million is the total value of Sio Capital Management, LLC's 45 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SNSS | Exit | SUNESIS PHARMACEUTICALS INC | $0 | – | -33,710 | -100.0% | -0.03% | – |
| PFNX | Exit | PFENEX INC | $0 | – | -85,867 | -100.0% | -0.13% | – |
| OTIC | Exit | OTONOMY INCput | $0 | – | -100,900 | -100.0% | -0.17% | – |
| OTIC | Exit | OTONOMY INC | $0 | – | -100,900 | -100.0% | -0.17% | – |
| CBAY | Exit | CYMABAY THERAPEUTICS INC | $0 | – | -75,000 | -100.0% | -0.31% | – |
| AGLE | Exit | AEGLEA BIO THERAPEUTICS INC | $0 | – | -129,583 | -100.0% | -0.33% | – |
| ACHC | Exit | ACADIA HEALTHCARE COMPANY INCput | $0 | – | -13,800 | -100.0% | -0.34% | – |
| DBVT | Exit | DBV TECHNOLOGIES SAput | $0 | – | -18,200 | -100.0% | -0.40% | – |
| ATNM | Exit | ACTINIUM PHARMACEUTICALS INC | $0 | – | -1,590,267 | -100.0% | -0.48% | – |
| AVDL | Exit | AVADEL PHARMACEUTICALS PLCsponsored adr | $0 | – | -91,413 | -100.0% | -0.50% | – |
| MDGL | Exit | MADRIGAL PHARMACEUTICALS INC | $0 | – | -26,958 | -100.0% | -0.63% | – |
| EVH | Exit | EVOLENT HEALTH INCcl a | $0 | – | -78,600 | -100.0% | -0.73% | – |
| ARNA | Exit | ARENA PHARMACEUTICALS INC | $0 | – | -72,086 | -100.0% | -0.95% | – |
| SNY | Exit | SANOFI SAsponsored adr | $0 | – | -45,099 | -100.0% | -1.16% | – |
| LMNX | Exit | LUMINEX CORP | $0 | – | -115,979 | -100.0% | -1.22% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -20,225 | -100.0% | -1.23% | – |
| ITGR | Exit | INTEGER HOLDINGS CORP | $0 | – | -51,258 | -100.0% | -1.36% | – |
| ZTS | Exit | ZOETIS INCput | $0 | – | -50,000 | -100.0% | -1.65% | – |
| ZBH | Exit | ZIMMER BIOMET HOLDINGS INC | $0 | – | -31,033 | -100.0% | -1.89% | – |
| EGRX | Exit | EAGLE PHARMACEUTICALS INC | $0 | – | -63,835 | -100.0% | -1.98% | – |
| HYH | Exit | HALYARD HEALTH INC | $0 | – | -86,914 | -100.0% | -2.03% | – |
| GSK | Exit | GLAXOSMITHKLINE PLCcall | $0 | – | -100,000 | -100.0% | -2.11% | – |
| MDT | Exit | MEDTRONIC PLC | $0 | – | -55,844 | -100.0% | -2.25% | – |
| GMED | Exit | GLOBUS MEDICAL INCcl a | $0 | – | -147,364 | -100.0% | -2.27% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -15,549 | -100.0% | -2.53% | – |
| SGEN | Exit | SEATTLE GENETICS INCput | $0 | – | -100,000 | -100.0% | -2.82% | – |
| AGIO | Exit | AGIOS PHARMACEUTICALS INCput | $0 | – | -83,100 | -100.0% | -2.88% | – |
| AXGT | Exit | AXOVANT SCIENCES LTD | $0 | – | -1,118,894 | -100.0% | -3.99% | – |
| INSM | Exit | INSMED INCput | $0 | – | -266,800 | -100.0% | -4.32% | – |
| ADMP | Exit | ADAMIS PHARMACEUTICALS CORP | $0 | – | -1,935,961 | -100.0% | -5.25% | – |
| AXGT | Exit | AXOVANT SCIENCES LTDput | $0 | – | -3,638,700 | -100.0% | -12.99% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VIKING THERAPEUTICS INC | 24 | Q3 2023 | 3.4% |
| UNITED THERAPEUTICS ORD | 23 | Q3 2023 | 8.3% |
| CARDINAL HEALTH ORD | 20 | Q2 2022 | 7.2% |
| SANOFI SA | 19 | Q3 2022 | 9.8% |
| MEDTRONIC PLC | 18 | Q3 2023 | 5.2% |
| CATALYST BIOSCIENCES INC | 18 | Q3 2021 | 17.8% |
| PFENEX ORD | 18 | Q4 2019 | 5.9% |
| AEGLEA BIOTHERAPEUTICS INC | 18 | Q1 2023 | 1.1% |
| HCA HEALTHCARE INC | 17 | Q2 2022 | 5.5% |
| MCKESSON ORD | 17 | Q1 2022 | 6.0% |
View Sio Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Modular Medical, Inc. | February 13, 2023 | 1,091,479 | 10.0% |
| Cellectar Biosciences, Inc. | February 10, 2022 | ? | ? |
| CURIS INC | February 10, 2022 | 3,866,645 | 4.2% |
| Salarius Pharmaceuticals, Inc. | February 10, 2022 | 1,354,291 | 3.0% |
| Larimar Therapeutics, Inc. | February 16, 2021 | 188,661 | 1.2% |
| ACHIEVE LIFE SCIENCES, INC. | February 14, 2020 | ? | ? |
| Bionano Genomics, Inc | February 14, 2020 | 1,210,821 | 4.6% |
| Brickell Biotech, Inc. | February 14, 2020 | ? | ? |
| Trillium Therapeutics Inc. | February 14, 2020 | 2,751,186 | 9.8% |
| ZAFGEN, INC. | February 14, 2020 | 2,283,164 | 6.1% |
View Sio Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| SC 13G | 2023-02-13 |
View Sio Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.